Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

Automated identification and quantification of myeloblasts among myeloid lineage cells on bone marrow biopsy using deep learning aligns with hematopathologist readings in patients with Acute Myeloid Leukemia and high-risk myelodysplastic syndrome

Zelin Zhang, Joshua Mercer, Megan Molnar, Ronald Sobecks, Howard Meyerson, Sara Arabyarmohammadi, Leland Metheny, Anant Madabhushi, Sanghee Hong

Blood (2025) 146 (Supplement 1): 7879.

https://doi.org/10.1182/blood-2025-7879

Published: 2025

Journal Articles

Phase 1 assessment of novel transposon BAFF CAR-T cells (LMY-920) for non-Hodgkin lymphoma (NHL) and multiple myeloma (MM)

Paolo Caimi, Leland Metheny, Matthew Spear, Jeff Liter, Branden Moriarity, Beau Webber

Blood (2025) 146 (Supplement 1): 1954.

https://doi.org/10.1182/blood-2025-1954

Published: 2025

Journal Articles

CD34 selected stem cell boost provides robust outcomes in patients with poor graft function

Sayan Mullick Chowdhury, Qiuhong Zhao, Sarah Wall, Hannah Choe, Sam Penza, Evandro Bezerra, Lynn Odonnell, Merle Kolk, Michael Daunov, Ashley Krull, Marcos de Lima, Leland Metheny, Sumithira Vasu

Blood (2025) 146 (Supplement 1): 7790.

https://doi.org/10.1182/blood-2025-7790

Published: 2025

Journal Articles

Safety and efficacy of transposon, BAFF-ligand directed chimeric antigen receptor T cells (LMY-920) with pre-apheresis obinutuzumab for patients with Relapsed/Refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

Paolo Caimi, Leland Metheny, Lapo Alinari, Changchun Deng, Matthew Spear, Jeff Liter, Branden Moriarity, Beau Webber, Jennifer Woyach, Brian Hill, J. Joseph Melenhorst

Blood (2025) 146 (Supplement 1): 4177.

https://doi.org/10.1182/blood-2025-4177

Published: 2025

Journal Articles

Phase 1 clinical trial of point-of-care manufactured, fully human anti-CD19 CAR-T cells for treatment of Relapsed/Refractory lymphoid malignancies

Nikki Agarwal, Brenda Cooper, Molly Gallogly, Leland Metheny, Changchun Deng, Ok-Kyong Chaekal, Rebecca Klisovic, Jane Reese, Dina Schneider, Rimas Orentas, Marcos de Lima, Koen van Besien, David Wald, Paolo Caimi, Ben Tomlinson

Blood (2025) 146 (Supplement 1): 5925.

https://doi.org/10.1182/blood-2025-5925

Published: 2025

Journal Articles

Avoidance of ATG improves outcomes in double-cord blood transplantation for hematological malignancies

Leland Metheny, Tao Wang, Esteban Arrieta-Bolanos, Meilun He, Cara Benjamin, Yung-Tsi Bolon, Stephanie Lee, Filippo Milano

Blood (2025) 146 (Supplement 1): 2436.

https://doi.org/10.1182/blood-2025-2436

Published: 2025

Journal Articles

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma

Blood (2025) 145 (3): 290–299.

https://doi.org/10.1182/blood.2024024681

Published: 2025

Includes: Supplemental data

Journal Articles

Combined Effects of Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy and Acute Graft-Versus-Host Disease on Requiring Renal Replacement Therapy in US Patient Population - a Secondary CIBMTR Analysis

Udit Nangia, Leland Metheny, Deepak Chandramohan, Hari Naga Garapati, Prathap Simhadri, Neeraj Mahajan

Blood (2024) 144 (Supplement 1): 2154.

https://doi.org/10.1182/blood-2024-208833

Published: 2024

Journal Articles

Impact of Timing of Acute Graft-Versus-Host-Disease on Incidence of Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

Udit Nangia, Leland Metheny, Neeraj Mahajan

Blood (2024) 144 (Supplement 1): 1241.

https://doi.org/10.1182/blood-2024-202257

Published: 2024

Journal Articles

Effect of Age, Timing of Thrombotic Microangiopathy and Timing of Acute Graft-Versus-Host Disease on Overall Survival after Hematopoietic Stem Cell Transplantation

Udit Nangia, Leland Metheny, Neeraj Mahajan

Blood (2024) 144 (Supplement 1): 3530.

https://doi.org/10.1182/blood-2024-202240

Published: 2024

Journal Articles

A Phase II Study of Low Dose Melphalan with Thiotepa and Fludarabine As Preparative Regimen for Alternative Donor Transplantation

Nikki Agarwal, Pingfu Fu, Michael Daunov, Brenda W Cooper, Ben K. Tomlinson, Rebecca B. Klisovic, Marcos de Lima, Folashade Otegbeye, Changchun Deng, Yeritza Hernandez-Collazo, Jignesh Dalal, James Martin, Seunghee Margevicius, James J. Ignatz-Hoover, Ok-Kyong Chaekal, Molly Megan Gallogly, Koen van Besien, Leland Metheny

Blood (2024) 144 (Supplement 1): 2131.

https://doi.org/10.1182/blood-2024-210550

Published: 2024

Journal Articles

A Retrospective Study of C5b-9 and MASP2 Deposition in Skin Microvasculature As a Prognostic and Diagnostic Tool for Transplant-Associated Thrombotic Microangiopathy

Michael Daunov, John Sumodi, Nikki Agarwal, Molly Megan Gallogly, Leland Metheny, Ben K. Tomlinson, Rebecca B. Klisovic, Ali W. Bseiso, Brett Glotzbecker, Kord Honda, Koen van Besien

Blood (2024) 144 (Supplement 1): 2115.

https://doi.org/10.1182/blood-2024-212304

Published: 2024

Journal Articles

Real-World Trends of Cytokine Release Syndrome and Neurologic Events, and Pattern of Their Management Among Patients Receiving Axicabtagene Ciloleucel for Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) in the US: A CIBMTR Report

Jiasheng Wang, Shakthi Bhaskar, Babatunde Adedokun, Olalekan O. Oluwole, Leland Metheny, Amy Moskop, Caron A. Jacobson, Geoffrey Shouse, Sairah Ahmed, Armin Ghobadi, Saurabh Dahiya, Jiali Yan, Zhen-Huan Hu, Timothy Best, Jenny J. Kim, Debbie L. Mirjah, Marcelo C. Pasquini, Frederick L. Locke

Blood (2024) 144 (Supplement 1): 527.

https://doi.org/10.1182/blood-2024-209093

Published: 2024

Journal Articles

Risk Factors for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation By Disease Groups in Competing Risk Analysis

Udit Nangia, Leland Metheny, Neeraj Mahajan

Blood (2024) 144 (Supplement 1): 1239.

https://doi.org/10.1182/blood-2024-202248

Published: 2024

Journal Articles

Vactosertib, a Novel TGFb Type I Receptor Kinase Inhibitor, Improves T-Cell Fitness:a Single-Arm, Phase 1b Trial in Relapsed/Refractory Multiple Myeloma

Ehsan Malek, Priyanka S. Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J. Ignatz-Hoover, Leland Metheny, Seong-Jin Kim, James J. Driscoll, II

Blood (2023) 142 (Supplement 1): 4749.

https://doi.org/10.1182/blood-2023-172711

Published: 2023

Journal Articles

A Phase I Clinical Trial of Fully Human Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

Brenda W Cooper, Molly Megan Gallogly, Leland Metheny, Rebecca B. Klisovic, Kirsten Marie Boughan, Jane Reese Koc, Darong Wu, Changchun Deng, Koen Van Besien, Rose Tupta, Dina Schneider, Lisa Ciarrone, Marcos de Lima, Paolo F. Caimi, Benjamin K. Tomlinson

Blood (2023) 142 (Supplement 1): 6872.

https://doi.org/10.1182/blood-2023-191153

Published: 2023

Journal Articles

African American Race Is a Potential Favorable Biologic Factor That Impacts Clinical Outcome for Patients with Multiple Myeloma

Jeries Kort, Leland Metheny, Pingfu Fu, Shufen Cao, James J. Driscoll, Ehsan Malek

Blood (2022) 140 (Supplement 1): 7244–7245.

https://doi.org/10.1182/blood-2022-170717

Published: 2022

Journal Articles

Circulating Tumor DNA Correlation with Lymphoma Response and Survival Outcomes at Multiple Time Points of Anti - CD19 CAR T Cell Therapy

Paolo F Caimi, Martina Di Trani, Armin Ghobadi, Jane Reese, Benjamin Tomlinson, Folashade Otegbeye, Kirsten M Boughan, Molly Gallogly, Leland Metheny, Brenda W. Cooper, Boro Dropulic, Marcos J.G. de Lima, Carmelo Carlo-Stella

Blood (2022) 140 (Supplement 1): 7457–7459.

https://doi.org/10.1182/blood-2022-170629

Published: 2022

Journal Articles

Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Leland Metheny, Ronald M. Sobecks, Christina Cho, Jiasheng Wang, Lisa Ciarrone, Paolo F. Caimi, Folashade Otegbeye, Brenda W. Cooper, Molly Gallogly, Ehsan Malek, Aaron T. Gerds, Betty K. Hamilton, Sergio A Giralt, Miguel-Angel Perales, Marcos J.G. de Lima

Blood (2022) 140 (Supplement 1): 1887–1889.

https://doi.org/10.1182/blood-2022-169935

Published: 2022

Journal Articles

Safety of Subcutaneous Daratumumab/ Hyaluronidase after Intravenous Daratumumab for Patients with Multiple Myeloma

Melissa Copley, Leland Metheny, Rebecca B. Klisovic, Ehsan Malek

Blood (2022) 140 (Supplement 1): 13202–13203.

https://doi.org/10.1182/blood-2022-162665

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Automated identification and quantification of myeloblasts among myeloid lineage cells on bone marrow biopsy using deep learning aligns with hematopathologist readings in patients with Acute Myeloid Leukemia and high-risk myelodysplastic syndrome

Phase 1 assessment of novel transposon BAFF CAR-T cells (LMY-920) for non-Hodgkin lymphoma (NHL) and multiple myeloma (MM)

CD34 selected stem cell boost provides robust outcomes in patients with poor graft function

Safety and efficacy of transposon, BAFF-ligand directed chimeric antigen receptor T cells (LMY-920) with pre-apheresis obinutuzumab for patients with Relapsed/Refractory chronic lymphocytic leukemia and small lymphocytic lymphoma

Phase 1 clinical trial of point-of-care manufactured, fully human anti-CD19 CAR-T cells for treatment of Relapsed/Refractory lymphoid malignancies

Avoidance of ATG improves outcomes in double-cord blood transplantation for hematological malignancies

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma

Combined Effects of Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy and Acute Graft-Versus-Host Disease on Requiring Renal Replacement Therapy in US Patient Population - a Secondary CIBMTR Analysis

Impact of Timing of Acute Graft-Versus-Host-Disease on Incidence of Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

Effect of Age, Timing of Thrombotic Microangiopathy and Timing of Acute Graft-Versus-Host Disease on Overall Survival after Hematopoietic Stem Cell Transplantation

A Phase II Study of Low Dose Melphalan with Thiotepa and Fludarabine As Preparative Regimen for Alternative Donor Transplantation

A Retrospective Study of C5b-9 and MASP2 Deposition in Skin Microvasculature As a Prognostic and Diagnostic Tool for Transplant-Associated Thrombotic Microangiopathy

Real-World Trends of Cytokine Release Syndrome and Neurologic Events, and Pattern of Their Management Among Patients Receiving Axicabtagene Ciloleucel for Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) in the US: A CIBMTR Report

Risk Factors for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation By Disease Groups in Competing Risk Analysis

Vactosertib, a Novel TGFb Type I Receptor Kinase Inhibitor, Improves T-Cell Fitness:a Single-Arm, Phase 1b Trial in Relapsed/Refractory Multiple Myeloma

A Phase I Clinical Trial of Fully Human Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

African American Race Is a Potential Favorable Biologic Factor That Impacts Clinical Outcome for Patients with Multiple Myeloma

Circulating Tumor DNA Correlation with Lymphoma Response and Survival Outcomes at Multiple Time Points of Anti - CD19 CAR T Cell Therapy

Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Safety of Subcutaneous Daratumumab/ Hyaluronidase after Intravenous Daratumumab for Patients with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only